EQL Pharma Future Growth
Future criteria checks 5/6
EQL Pharma wird ein jährliches Wachstum der Gewinne und Einnahmen um 81.2% bzw. 47% prognostiziert, während der Gewinn pro Aktie um 81% auf grow steigen dürfte.
Key information
81.2%
Earnings growth rate
81.0%
EPS growth rate
Healthcare earnings growth | 33.3% |
Revenue growth rate | 47.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Feb 2024 |
Recent future growth updates
No updates
Recent updates
EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 21The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested
Jun 28With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case
Apr 28EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors
Feb 24EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital
Dec 19Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?
Jun 29Is EQL Pharma (NGM:EQL) Using Too Much Debt?
Apr 29We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair
Aug 10EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns
Jun 07If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late
Apr 16How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?
Mar 11Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 21Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 03What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation
Jan 16Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?
Dec 28What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?
Dec 11EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment
Nov 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2025 | 485 | 89 | N/A | N/A | 1 |
3/31/2024 | 363 | 60 | N/A | N/A | 1 |
12/31/2023 | 246 | 22 | -47 | 19 | N/A |
9/30/2023 | 256 | 28 | -11 | 12 | N/A |
6/30/2023 | 270 | 30 | -18 | 3 | N/A |
3/31/2023 | 260 | 31 | 7 | 28 | N/A |
12/31/2022 | 403 | 33 | 15 | 29 | N/A |
9/30/2022 | 440 | 39 | 34 | 51 | N/A |
6/30/2022 | 419 | 36 | 41 | 63 | N/A |
3/31/2022 | 410 | 32 | 20 | 42 | N/A |
12/31/2021 | 233 | 19 | -6 | 49 | N/A |
9/30/2021 | 145 | 4 | -24 | 40 | N/A |
6/30/2021 | 117 | 2 | -66 | -5 | N/A |
3/31/2021 | 179 | 10 | 4 | 60 | N/A |
12/31/2020 | 172 | 17 | -10 | 28 | N/A |
9/30/2020 | 163 | 16 | -5 | 20 | N/A |
6/30/2020 | 157 | 14 | 50 | 65 | N/A |
3/31/2020 | 72 | 3 | -11 | 7 | N/A |
12/31/2019 | 68 | 2 | -13 | 3 | N/A |
9/30/2019 | 58 | -2 | -2 | 14 | N/A |
6/30/2019 | 54 | -2 | -12 | 8 | N/A |
3/31/2019 | 50 | -2 | -10 | 6 | N/A |
12/31/2018 | 43 | -2 | 1 | 10 | N/A |
9/30/2018 | 41 | 0 | N/A | N/A | N/A |
6/30/2018 | 35 | 0 | -22 | -3 | N/A |
3/31/2018 | 32 | -1 | -20 | -2 | N/A |
12/31/2017 | 30 | 1 | -4 | -4 | N/A |
9/30/2017 | 30 | 0 | N/A | -11 | N/A |
6/30/2017 | 26 | 0 | N/A | -7 | N/A |
3/31/2017 | 24 | 0 | N/A | 1 | N/A |
12/31/2016 | 31 | 4 | N/A | 1 | N/A |
9/30/2016 | 29 | 5 | N/A | 10 | N/A |
6/30/2016 | 34 | 6 | N/A | 6 | N/A |
3/31/2016 | 35 | 7 | N/A | 2 | N/A |
12/31/2015 | 29 | 4 | N/A | 0 | N/A |
9/30/2015 | 26 | 1 | N/A | -9 | N/A |
6/30/2015 | 21 | -2 | N/A | -7 | N/A |
3/31/2015 | 19 | -5 | N/A | -11 | N/A |
12/31/2014 | 18 | -9 | N/A | -12 | N/A |
9/30/2014 | 19 | -11 | N/A | -9 | N/A |
6/30/2014 | 19 | -12 | N/A | -8 | N/A |
3/31/2014 | 20 | -11 | N/A | -6 | N/A |
12/31/2013 | 22 | -8 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: EQLDas prognostizierte Gewinnwachstum (66.8% pro Jahr) liegt über der Sparquote (0.8%).
Ertrag vs. Markt: EQLDie Erträge des Unternehmens (66.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (13.5% pro Jahr).
Hohe Wachstumserträge: EQLEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: EQLDie Einnahmen des Unternehmens (40.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (-0.01% pro Jahr).
Hohe Wachstumseinnahmen: EQLDie Einnahmen des Unternehmens (40.3% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von EQL in 3 Jahren voraussichtlich hoch sein wird